Comparison of sodium-glucose cotransporter-2 inhibitors and thiazolidinediones for management of non-alcoholic fatty liver disease: A systematic review and meta-analysis
{{output}}
Background: The pharmacologic treatment of non-alcoholic fatty liver disease (NAFLD) remains unclear. Methods: Two reviewers searched PubMed, S... ...
